Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Aflac (AFL) through the VizualStocks API.
Total adjusted revenue of Aflac's Corporate and Other activities, including the parent company, reinsurance operations and intercompany eliminations, in USD. It includes net earned premiums, adjusted investment income and other income, excluding adjusted investment gains and losses.
corporateOtherAdjustedRevenuePretax adjusted earnings of Aflac's Corporate and Other activities, including the parent company, reinsurance operations and intercompany eliminations, before management fees, in USD. This is the issuer's segment performance measure after benefits and adjusted expenses, rather than consolidated GAAP net earnings.
corporateOtherPretaxAdjustedEarningsAdjusted net investment income of Aflac Japan, which sells cancer, medical and other life and health insurance in Japan, in USD. It includes amortized currency hedge costs or income and investment-strategy derivative interest reclassified from investment gains and losses.
japanAdjustedNetInvestmentIncomeTotal adjusted revenue of Aflac Japan, which sells cancer, medical and other life and health insurance in Japan, in USD. It includes net earned premiums, adjusted investment income and other income, excluding adjusted investment gains and losses.
japanAdjustedRevenueNet earned insurance premiums of Aflac Japan, which sells cancer, medical and other life and health insurance in Japan, including assumed premiums and net of ceded reinsurance, in USD. Includes the deferred profit liability presentation change in LDTI-recast history beginning in 2021.
japanNetEarnedPremiumsAnnual premiums on new Aflac Japan applications submitted during the year, including incremental premiums from policy upgrades, translated to USD as reported by Aflac. This assumes coverage remains in force for 12 months and is a sales measure, not earned revenue.
japanNewAnnualizedPremiumSalesPercentage of Aflac Japan premiums remaining in force, reported on a trailing 12-month basis at the period end. This series starts in 2025, when Aflac began excluding annuitizations, premium halving and premium waivers from terminations; earlier periods were not recast.
japanPremiumPersistencyPretax adjusted earnings of Aflac Japan, which sells cancer, medical and other life and health insurance in Japan, before management fees, in USD. This is the issuer's segment performance measure after benefits and adjusted expenses, rather than consolidated GAAP net earnings.
japanPretaxAdjustedEarningsAdjusted net investment income of Aflac U.S., which sells supplemental health and life insurance to U.S. employers and individuals, in USD. It includes amortized currency hedge costs or income and investment-strategy derivative interest reclassified from investment gains and losses.
usAdjustedNetInvestmentIncomeTotal adjusted revenue of Aflac U.S., which sells supplemental health and life insurance to U.S. employers and individuals, in USD. It includes net earned premiums, adjusted investment income and other income, excluding adjusted investment gains and losses.
usAdjustedRevenueNet earned insurance premiums of Aflac U.S., which sells supplemental health and life insurance to U.S. employers and individuals, including assumed premiums and net of ceded reinsurance, in USD. History uses the issuer's LDTI-recast basis beginning in 2021.
usNetEarnedPremiumsAnnual premiums on new Aflac U.S. policies and riders issued during the period, including incremental premiums from policy upgrades, in USD. This assumes coverage remains in force for 12 months and is a sales measure, not earned revenue.
usNewAnnualizedPremiumSalesPercentage of Aflac U.S. premiums remaining in force, reported on a trailing 12-month basis at the period end. From 2021 the disclosed population includes network dental and vision, consumer markets and Group Premier products.
usPremiumPersistencyPretax adjusted earnings of Aflac U.S., which sells supplemental health and life insurance to U.S. employers and individuals, before management fees, in USD. This is the issuer's segment performance measure after benefits and adjusted expenses, rather than consolidated GAAP net earnings.
usPretaxAdjustedEarnings